![Andrew Gengos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Gengos
Director of Finance/CFO at
IMMUNEERING CORPORATION
Net worth: 1 M $ as of 2026-06-29
Profile
Andrew W.
Gengos is currently Director at Turn Therapeutics (TM), Inc., Independent Director at Turn Therapeutics, Inc. since 2020, Director at Seneca Therapeutics, Inc. starting 2025, and Chief Financial Officer & Treasurer at Immuneering Corp.
starting 2026.
Former positions include President, Chief Executive Officer & Director at ImmunoCellular Therapeutics Ltd. from 2012 to 2016; President, Chief Executive Officer & Director at Neuraltus Pharmaceuticals, Inc. from 2010 to 2012; Vice President-Strategy & Corporate Development at Amgen, Inc. from 2002 to 2010; Senior Manager-Engagement at McKinsey & Co., Inc. from 1991 to 1998; Chief Business Officer at Cyteir Therapeutics, Inc. from 2020 to 2023; COO & Head-Corporate Development at Synlogic, Inc. from 2017 to 2018; Chief Financial & Business Officer at AOBiome Therapeutics, Inc. in 2019; Chief Financial & Business Officer at LeonaBio, Inc. from 2023 to 2024; Chief Financial & Accounting Officer at Terns Pharmaceuticals, Inc. from 2025 to 2026; Vice President-Strategy & Development at Chiron Corp.
in 2010; Vice President-Strategy & Corporate Development at Relypsa, Inc. in 2010; Director at Allozyne, Inc.; Chief Financial & Business Officer at Dynavax Technologies Corp.
The education history includes undergraduate studies at Massachusetts Institute of Technology and an MBA from UCLA Anderson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-15 | 225,000 ( 0.35% ) | 1 M $ | 2026-06-29 | |
| 2026-06-03 | 10,000 ( 0.03% ) | 73 000 $ | 2026-06-29 |
Andrew Gengos active positions
| Companies | Position | Start |
|---|---|---|
| TURN THERAPEUTICS INC. | Director/Board Member | 2019-12-31 |
| IMMUNEERING CORPORATION | Director of Finance/CFO | 2026-07-15 |
Seneca Therapeutics, Inc.
 Seneca Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel oncolytic immunotherapeutics | Director/Board Member | 2025-02-28 |
Turn Therapeutics(TM), Inc
 Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Develops antibiotic resistance medicines | Director/Board Member | - |
Former positions of Andrew Gengos
| Companies | Position | End |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Director of Finance/CFO | 2026-04-30 |
| LEONABIO, INC. | Director of Finance/CFO | 2024-09-30 |
| CYTEIR THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-02-02 |
AOBiome Therapeutics, Inc.
 AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions | Director of Finance/CFO | 2019-11-30 |
| SYNLOGIC, INC. | Chief Operating Officer | 2018-11-30 |
Training of Andrew Gengos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Allozyne, Inc.
 Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Neuraltus Pharmaceuticals, Inc.
 Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes molecule therapeutics | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Seneca Therapeutics, Inc.
Seneca Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel oncolytic immunotherapeutics | Commercial Services |
Turn Therapeutics(TM), Inc
Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Develops antibiotic resistance medicines | Health Technology |
Global Health Solutions Inc
 Global Health Solutions Inc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and medical device development company that provides solutions for dermatological diseases | Health Technology |
- Stock Market
- Insiders
- Andrew Gengos
